LON:AZN - AstraZeneca Share Price, Forecast & News

AstraZeneca trades on the London Stock Exchange (LON) under the ticker symbol "AZN."

AstraZeneca announced a dividend on Thursday, July 25th. Investors of record on Thursday, August 8th will be given a dividend of GBX 71.90 per share on Monday, September 9th. This represents a yield of 1.07%. The ex-dividend date of this dividend is Thursday, August 8th. The official announcement can be seen at this link. View AstraZeneca's Dividend History.

AstraZeneca is scheduled to release their next quarterly earnings announcement on Friday, February 14th 2020. View Earnings Estimates for AstraZeneca.

16 Wall Street analysts have issued twelve-month price objectives for AstraZeneca's stock. Their forecasts range from GBX 5,800 to £100. On average, they expect AstraZeneca's share price to reach GBX 7,912.14 in the next twelve months. This suggests a possible upside of 3.3% from the stock's current price. View Analyst Price Targets for AstraZeneca.

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AstraZeneca in the last year. There are currently 3 sell ratings, 2 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for AstraZeneca.

Media stories about AZN stock have trended extremely negative on Sunday, InfoTrie reports. The research group identifies positive and negative news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. AstraZeneca earned a news sentiment score of -4.5 on InfoTrie's scale. They also assigned media stories about the biopharmaceutical company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company's share price in the next few days. View News Stories for AstraZeneca.

Some companies that are related to AstraZeneca include GlaxoSmithKline (GSK), Bayer (BAYN), Dechra Pharmaceuticals (DPH), Hutchison China MediTech (HCM), Opthea (OPT), Mayne Pharma Group (MYX), Medical Developments International (MVP), Vectura Group (VEC), Eco Animal Health Group (EAH), BEXIMCO PHARMAC/S GDR REGS (BXP), Trilogy International Partners (TRL), Allergy Therapeutics (AGY), Pharmaxis (PXS), Recce Pharmaceuticals (RCE) and Vita Life Sciences (VLS).

Based on aggregate information from My MarketBeat watchlists, some companies that other AstraZeneca investors own include GlaxoSmithKline (GSK), Hain Celestial Group (HAIN), Vodafone Group (VOD), NVIDIA (NVDA), National Retail Properties (NNN), BP (BP), Royal Dutch Shell (RDSB), Marks and Spencer Group (MKS), Encana (ECA) and Philip Morris International (PM).

Shares of AZN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

One share of AZN stock can currently be purchased for approximately GBX 7,659.

AstraZeneca has a market capitalization of £100.50 billion and generates £24.14 billion in revenue each year. AstraZeneca employs 64,400 workers across the globe.View Additional Information About AstraZeneca.

The official website for AstraZeneca is http://www.astrazeneca.com/.

AstraZeneca's mailing address is 1 Francis Crick Avenue Cambridge Biomedical Campus, CAMBRIDGE, CB2 0AA, United Kingdom. The biopharmaceutical company can be reached via phone at +44-20-73045000.